Sample quality control in vaccine development

Boost Your RNA Vaccine Development

Reliable QC. Informed decisions.

New White Paper

RNA Vaccines: History, Current Status, and Future Applications

IVT RNA vaccines are manufactured using robust processes guided by good manufacturing practices (GMP). GMPs include quality monitoring via sample quality control (QC) checks. Sample QC can be quickly and easily accomplished using automated electrophoresis solutions. These solutions can provide confident sample quality control during the development and production of vaccines for therapeutic applications including:

Emerging SARS-CoV-2 variants
Influenza and other viruses
Various cancers

In this white paper, read how Agilent Fragment Analyzer, TapeStation, and Bioanalyzer, systems are being applied to the sample quality control of IVT RNA vaccines and enabling scientists to make informed decisions.

Get your copy

For Research Use Only. Not for use in diagnostic procedures.

Sign up here

Fill in your details to receive your free copy of the white paper "Quality Assurance in In Vitro Transcribed (IVT) RNA Vaccine Development using Agilent Automated Electrophoresis Instruments."

Boost Your RNA Vaccine Development

New White Paper

RNA Vaccines: History, Current Status, and Future Applications

Sign up here

Personal Data

Purchase Plan